Alxa High-tech Zone is making efforts to extend, complete and strengthen its industrial chain, guiding the fine chemical industry towards downstream products and helping the zone take new steps in high-quality development.
Recently, the first batch of finished disinfectant products of Inner Mongolia Hengdeli Biotechnology Co., Ltd. rolled off the production line, marking a breakthrough from "zero" in the production and sales of finished pharmaceuticals in Alxa High-tech Zone. Inner Mongolia Hengdeli Biotechnology Co., Ltd. is the first enterprise in our league to register on the National Disinfection Product Filing Network. Its main products are solid disinfectants; among them, the chlorine-containing effervescent tablets produced during the epidemic became the zone's first proprietary brand product, applicable to industrial circulating water treatment, waste treatment, swimming pools, disinfection of medical devices and household disinfection, and are exported to Southeast Asia and other regions.
Wang Yihua, General Manager of Inner Mongolia Hengdeli Biotechnology Co., Ltd.
“In the future, we will focus on channel development and product segmentation and upgrading of disinfectants for the consumer market, promoting and operating products through both online and offline channels, so that the product philosophy of "a new realm of quality disinfection" reaches thousands of households.”
Alxa High-tech Zone bases itself on the actual conditions of the park and, relying on abundant basic chemical raw materials, has developed competitive products in segments such as pesticide technical materials, pesticide intermediates, veterinary drug technical materials, pharmaceutical intermediates and formulations. Through the circular extension of the fine chemical chain, it keeps upgrading the innovation chain.
Inner Mongolia Qihui Pharmaceutical Co., Ltd. is an enterprise in the zone engaged in the R&D, production and sales of veterinary APIs, APIs and their intermediates. Its flagship products are imidazole anthelmintics, covering most links of the veterinary drug chain, with particularly large volumes of APIs and intermediates — its albendazole and fenbendazole sales account for more than 60% of the global market. At present, the company is cooperating with the Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS to develop veterinary drug formulation projects, integrating the upstream, midstream and downstream of the chain.
Zhu Jianmin, Chairman of Inner Mongolia Qihui Pharmaceutical Co., Ltd.
“We have so far obtained veterinary drug production approval numbers for five products. Next, we will extend the product chain into veterinary drug formulations, achieving integrated development of intermediates and API formulations.”
Alxa High-tech Zone is speeding up the construction of a diversified, integrated and circular development model for modern medicine, pesticides and veterinary drugs, making a scientific layout to extend, fill and strengthen the industrial chain — consolidating the "foundation" of upstream raw materials, expanding the scale of midstream finished products, and cultivating downstream supporting products.
Qu Jianyang, Deputy Director of the Economic Development Bureau of the High-tech Zone
“We will continue to extend and complete the fine chemical chain, keep a close eye on the "gaps" and weaknesses in modern medicine, pesticides and veterinary drugs, and carry out supplementary and gap-filling investment promotion. At the same time, we will serve enterprises proactively and with high quality.”
Source: Public reports of the Alxa High-tech Zone Administration and local media
OEM / ODM available. Customers at home and abroad are welcome to contact us.
Contact Us